Reports for MINT PHARMACEUTICALS INC
Company Name
MINT PHARMACEUTICALS INC
Totals |
||
Shortage reports |
132 |
|
| Actual shortage: | 30 (23%) | |
| Anticipated shortage: | 0 (0%) | |
| Avoided shortage: | 0 (0%) | |
| Resolved: | 102 (77%) | |
Discontinuation Reports |
29 |
|
| To be discontinued: | 0 (0%) | |
| Discontinued: | 29 (100%) | |
| Reversed: | 0 (0%) | |
Late reports |
33 (20%) |
|
Overdue reports |
15 (50%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| MINT-DICLOFENAC | 0.1% | SOLUTION | Actual shortage | 2023-03-27 | 2023-09-27 | 188042 |
| MINT-DICLOFENAC | 0.1% | SOLUTION | Actual shortage | 2023-03-27 | 2023-09-27 | 188045 |
| MINT-ESCITALOPRAM | 20MG | TABLET | Resolved | 2019-12-09 | 2020-06-09 | 100585 |
| MINT-TRAMADOL/ACET | 37.5MG 325MG | TABLET | Resolved | 2019-10-09 | 2019-12-10 | 95944 |
| MINT-ALENDRONATE | 70.0MG | TABLET | Actual shortage | 2024-01-26 | 2024-01-26 | 217366 |
| MINT-AMLODIPINE | 5MG | TABLET | Resolved | 2017-11-21 | 2018-01-11 | 30002 |
| MINT-ANASTROZOLE | 1MG | TABLET | Resolved | 2024-01-26 | 2024-03-26 | 217369 |
| MINT-CANDESARTAN | 8MG | TABLET | Resolved | 2019-04-08 | 2019-06-15 | 80787 |
| MINT-CANDESARTAN | 8MG | TABLET | Resolved | 2019-07-24 | 2019-12-09 | 89913 |
| MINT-CANDESARTAN | 8MG | TABLET | Resolved | 2019-10-09 | 2019-11-29 | 95947 |
| MINT-CANDESARTAN | 16MG | TABLET | Resolved | 2019-01-03 | 2019-11-29 | 71041 |
| MINT-CIPROFLOX | 500MG | TABLET | Resolved | 2018-07-31 | 2020-03-21 | 57055 |
| MINT-CITALOPRAM | 40MG | TABLET | Resolved | 2018-04-12 | 2018-05-16 | 45533 |
| MINT-CLOPIDOGREL | 75MG | TABLET | Actual shortage | 2018-03-09 | 2018-03-10 | 42370 |
| MINT-CLOPIDOGREL | 75MG | TABLET | Actual shortage | 2018-04-06 | 2018-04-07 | 45117 |
| MINT-DULOXETINE | 60MG | CAPSULE (DELAYED RELEASE) | Resolved | 2018-04-12 | 2018-05-08 | 45539 |
| MINT-DUTASTERIDE | 0.5MG | CAPSULE | Resolved | 2018-01-04 | 2018-02-23 | 34914 |
| MINT-FENOFIBRATE E | 145MG | TABLET | Actual shortage | 2019-04-08 | 2020-04-25 | 80782 |
| MINT-FLUOXETINE | 10MG | CAPSULE | Resolved | 2018-07-31 | 2021-01-11 | 57064 |
| MINT-FLUOXETINE | 20MG | CAPSULE | Resolved | 2018-07-31 | 2021-01-11 | 57069 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| MINT-LEVOFLOXACIN | 750MG | TABLET | Discontinued | 2022-10-02 | 2022-10-03 | 170859 |
| MINT-METFORMIN | 500MG | TABLET | Discontinued | 2019-07-04 | 2019-07-05 | 88513 |
| MINT-RIVASTIGMINE | 3MG | CAPSULE | Discontinued | 2017-06-21 | 2017-07-01 | 13556 |
| MINT-RIVASTIGMINE | 6MG | CAPSULE | Discontinued | 2017-06-21 | 2017-07-01 | 13559 |
| MINT-RIVASTIGMINE | 1.5MG | CAPSULE | Discontinued | 2017-06-21 | 2017-07-01 | 13562 |
| MINT-RIVASTIGMINE | 4.5MG | CAPSULE | Discontinued | 2017-06-21 | 2017-07-01 | 13565 |
| MINT-RIZATRIPTAN ODT | 5MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2017-06-21 | 2017-07-01 | 13544 |
| MINT-RIZATRIPTAN ODT | 10MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2017-06-21 | 2017-07-01 | 13553 |
| MINT-ZOLMITRIPTAN ODT | 2.5MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2017-06-21 | 2017-07-01 | 13540 |